Search - tctmd.com

Displaying 301 - 320 of 320

Sort: Relevancy | Date

Presentation TCT 2014

How Would I Treat This Patient?

Presenter: Matjaz Bunc, Ariel Finkelstein, Susheel Kodali, Georgios Sianos, Georgios C Bompotis

September 16, 2014

Presentation TCT 2014

Case #3: Left Main Intervention in ACS

Presenter: Matjaz Bunc, Ariel Finkelstein, Susheel Kodali, Georgios Sianos, Paul Fefer

September 16, 2014

News Daily News

Hospital-Acquired Thrombocytopenia Increases Risk of Hospital Bleeding, 1-Year Mortality

May 05, 2014

News Daily News

Los Balones liberadores de Fármacos Reducen la Reestenosis y la RLD en Pacientes Diabéticos con ICE

Yael L. Maxwell

February 26, 2014

News Daily News

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

Yael L. Maxwell

February 26, 2014

Presentation

DEB vs. Standard Angioplasty to Reduce Recurrent Restenosis in Diabetics with Femoropopliteal ISR

Presenter: Francesco Liistro

February 24, 2014

News Daily News

Radiation Exposure with Lower-Extremity Endovascular Interventions Surprisingly High

August 12, 2013

News Daily News

La Exposición a la Radiación derivada de Intervenciones Endovasculares de Extremidades Inferiores es Sorprendentemente Alta

August 12, 2013

News Conference News EuroPCR 2013

Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR

Jason Kahn

May 24, 2013

News Daily News

Rivaroxaban Added to Dual Antiplatelet Therapy Cuts Stent Thrombosis in ACS Patients

Caitlin E. Cox

April 19, 2013

News Daily News

Rivaroxaban + Terapia Antiplaquetaria Doble Reducen la Trombosis del Stent en Pacientes víctimas de un SCA

Caitlin E. Cox

April 19, 2013

News Conference News ACC 2013

Double-Kissing Crush Better than Culotte Technique for Left Main Bifurcation Stenting

Jason Kahn

March 09, 2013

News Daily News

Un Nuevo Anti Inflamatorio podría Reducir la Estenosis tras la Implantación de SMD en Pacientes de Alto Riesgo

L.A. McKeown

January 13, 2013

News Daily News

Novel Anti-inflammatory May Reduce Restenosis After BMS in High-Risk Patients

L.A. McKeown

January 13, 2013

Presentation TCT 2012

Case 2: Management of DES ISR with Drug Eluting Balloons

Presenter: Andrzej Ochala

October 26, 2012

Presentation TCT 2012

Case 1: Management of Focal DES ISR

Presenter: Ioannis Iakovou

October 26, 2012

News Conference News ACC 2012

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

L.A. McKeown

March 26, 2012

News Daily News

El Celecoxib Aumenta la Eficacia de los SLF a un determinado Coste Clínico

March 15, 2012

News Daily News

Celecoxib Enhances DES Efficacy, But at Clinical Cost

March 15, 2012

News Conference News

Paclitaxel Balloon Maintains Advantage at 5 Years

Caitlin E. Cox

May 20, 2011

Advertisement

How Would I Treat This Patient?

Case #3: Left Main Intervention in ACS

Hospital-Acquired Thrombocytopenia Increases Risk of Hospital Bleeding, 1-Year Mortality

Los Balones liberadores de Fármacos Reducen la Reestenosis y la RLD en Pacientes Diabéticos con ICE

Drug-Eluting Balloons Reduce Restenosis, TLR in Diabetic Patients with CLI

DEB vs. Standard Angioplasty to Reduce Recurrent Restenosis in Diabetics with Femoropopliteal ISR

Radiation Exposure with Lower-Extremity Endovascular Interventions Surprisingly High

La Exposición a la Radiación derivada de Intervenciones Endovasculares de Extremidades Inferiores es Sorprendentemente Alta

Deflection Device Reduces Volume, Not Number, of Cerebral Lesions During TAVR

Rivaroxaban Added to Dual Antiplatelet Therapy Cuts Stent Thrombosis in ACS Patients

Rivaroxaban + Terapia Antiplaquetaria Doble Reducen la Trombosis del Stent en Pacientes víctimas de un SCA

Double-Kissing Crush Better than Culotte Technique for Left Main Bifurcation Stenting

Un Nuevo Anti Inflamatorio podría Reducir la Estenosis tras la Implantación de SMD en Pacientes de Alto Riesgo

Novel Anti-inflammatory May Reduce Restenosis After BMS in High-Risk Patients

Case 2: Management of DES ISR with Drug Eluting Balloons

Case 1: Management of Focal DES ISR

Daily Rivaroxaban as Effective as Enoxaparin for Pulmonary Embolism

El Celecoxib Aumenta la Eficacia de los SLF a un determinado Coste Clínico

Celecoxib Enhances DES Efficacy, But at Clinical Cost

Paclitaxel Balloon Maintains Advantage at 5 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content